Breakpoint Therapeutics

Provider anti-cancer drug based on DNA repair mechanism

placeHamburg, Hamburg, Germany calendar_todayFounded 2019 groups5 employees language breakpointtx.com

Registered entities

Innovation

10 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 359 times.

YearFilings
20234
20245
20255
20261

Investor mix

2 investors on record; lead investors include Medicxi.

Investor typeCountShare
Venture capital2100%
Coming soon